Brighthouse Financial's Acquisition Plans Don't Change My Sell Rating for Preferred Stocks

jueves, 11 de septiembre de 2025, 8:02 am ET1 min de lectura
BHF--

Brighthouse Financial's potential acquisition does not change my PFD sell rating. The company's financials and performance remain a concern, and investors should be cautious about its preferred stocks. The acquisition does not address the underlying issues and could further weaken the company's financial position.

Brighthouse Financial, Inc. (NASDAQ: BHF) has seen a surge in its stock price, rising by 14% after reports emerged that Aquarian Holdings, a New York-based private capital group, is nearing the final stages of securing the necessary funding to acquire the US life insurer. This potential acquisition, if completed, would represent one of the largest insurance acquisitions in recent years, positioning Aquarian as a significant player in the sector Brighthouse Financial surges 14% as Aquarian nears takeover funding[2].

Brighthouse Financial, which was spun off from MetLife in 2017, is one of the last remaining large independent US life insurers. It manages nearly $120 billion in assets but has faced challenges in improving profitability and achieving its targeted capital ratios. The company's reliance on variable annuities, a complex and capital-intensive product, has weighed heavily on its financial results Brighthouse Financial surges 14% as Aquarian nears takeover funding[2].

The potential acquisition by Aquarian Holdings does not change the analyst's previous sell rating for Brighthouse Financial's preferred stocks (PFD). Despite the acquisition, the underlying financial issues remain a concern for investors. The coverage ratio for all four preferred stocks is still anemic at 2.4X, indicating a weak financial position Brighthouse Financial's Potential Acquisition Does Not Change My PFD Sell Rating[1]. While the acquisition might bring strategic benefits to the company, it does not address the fundamental financial challenges that Brighthouse faces.

The preferred stocks of Brighthouse Financial include Brighthouse Financial, 4.625% Series D Dep Shares Non-Cumul Perp Preferred Stock (NASDAQ: BHFAM), Brighthouse Financial, 5.375% Series C Dep Shares Non-Cumul Perp Preferred Stock (NASDAQ: BHFAN), Brighthouse Financial, 6.75% Series B Dep Shares Non-Cumul Perp Preferred Stock (NASDAQ: BHFAO), and Brighthouse Financial, 6.60% Series A Dep Shares Non-Cumul Perp Preferred Stock (NASDAQ: BHFAP) Brighthouse Financial's Potential Acquisition Does Not Change My PFD Sell Rating[1].

Investors should be cautious about the preferred stocks, as the acquisition does not guarantee improved financial health. The possibility of delisting, which occurred in other acquisitions where preferred stocks were involved, remains a risk. Additionally, the fact that the dividends are non-cumulative must be taken into serious consideration, especially for issuers with little asset coverage or a weak financial history Brighthouse Financial's Potential Acquisition Does Not Change My PFD Sell Rating[1].

In conclusion, while the potential acquisition by Aquarian Holdings is a positive development for Brighthouse Financial's common shareholders, it does not change the sell rating for the preferred stocks. Investors should remain cautious and closely monitor the company's financial performance and the progress of the acquisition.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios